Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Catriona Mairi McNeil
Based on 22 articles published since 2010
(Why 22 articles?)
||||
Expertise Level
The expertise of Catriona Mairi McNeil ranks in the
  • Top 0.52%
  • ... of 120,378 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 22 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases McNeil, Catriona M   ·   McNeil, C   ·   McNeil, Catriona Mairi   ·   McNeil, Catriona   ·   Mcneil, Catriona
Work Locations
Details
Most likely:    Royal Prince Alfred Hospital      
2019
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia. · Department of Medicine, Institute Gustave Roussy, Villejuif, France. · Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia. · Dermatology Service, University Hospital of Bordeaux, Bordeaux, France. · UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France. · Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. · Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Assistance Publique-Hôpitaux de Paris Dermatology and Centre d'Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France. · Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France. · Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Department of Dermatology, University Hospital Cologne, Cologne, Germany. · Division of Oncology, Regina Elena Institute, Rome, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark. · Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey. · Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia. · Pubmed 30422243
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, The University of Melbourne, 305 Grattan Street, Melbourne, VIC, 3000, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, CA, USA. · Genentech, Inc., South San Francisco, CA, USA. · Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. · The Angeles Clinic and Research Institute, California, Los Angeles, USA. · Sarah Cannon Research Institute/Tennessee Oncology, PPLC, Nashville, TN, USA. · Pubmed 31385109
2018
  • Chris O'Brien Lifehouse, Medical Oncology Department, Camperdown, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Wyong Public Hospital, Gastroenterology Department, NSW, Australia. · Pubmed 29370723
  • a Chris O'Brien Lifehouse , Sydney , Australia. · b Royal Prince Alfred Hospital , Sydney , Australia. · Pubmed 27892777
2017
  • Division of Oncology, Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. Electronic address: · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney, Mater Hospital and Royal North Shore Hospital, Sydney, Australia. · Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital de la Timone, Marseille, France. · Department of Dermatology, Université Lille, INSERM U1189, CHU Lille, F-59000, France. · Department of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, USA. · Department of Medical Oncology, Westmead and Blacktown Hospitals, Melanoma Institute Australia, and The University of Sydney, Sydney, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, and Melanoma Institute Australia, Camperdown, Australia. · Department of Melanoma and Cancer Immunotherapy, Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Department of Medical Oncology University of Manchester and the Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medicine, Division of Medical Oncology/Hematology, Sunnybrook Health Sciences Center, Toronto, ON, Canada. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Department of BARDS, Merck & Co, Kenilworth, NJ, USA. · Department of Clinical Oncology, Merck & Co, Kenilworth, NJ, USA. · Department of Oncology, Gustave Roussy and Paris-Sud University, Villejuif, France. · Pubmed 28822576
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Mater Hospital, North Sydney, New South Wales, Australia. · Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · now with Department of Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York. · Department of Oncology, Royal Marsden Hospital, London, United Kingdom. · Gallipoli Medical Research Foundation and Princess Alexandra Hospital, and University of Queensland, Queensland, Australia. · Department of Dermatology and Skin Cancer, Hospital Timone APHM, Aix-Marseille University, Marseille, France. · Department of Skin, University Hospital Essen, Essen, Germany. · Department of Urology, University Hospital Essen, Essen, Germany. · Department of Dermatology, UniversitaetsSpital, Zurich, Switzerland. · Department of Medicine Institute Gustave Roussy, Gustave Roussy and Paris-Sud University, Villejuif Paris-Sud, France. · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales, Australia. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Oncology, Coffs Harbour Health Campus, New South Wales, Australia. · Melanoma Clinic at King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium. · Melanoma Center and Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28662232
  • Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Centenary Institute, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Nepean Hospital, Sydney, New South Wales, Australia. · Kossard Dermatopathologists, Sydney, New South Wales, Australia. · Pathology North - Hunter, Newcastle, New South Wales, Australia. · John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia. · University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 28480561
2016
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • A.W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 25641691
  • aDoherty Institute for Infection and Immunity, University of Melbourne bDepartment of Infectious Diseases, Alfred Hospital and Monash University cCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria dDepartment of Medical Oncology eDepartment of Clinical Immunology, Royal Prince Alfred Hospital, Sydney fWestmead Millenium Institute, University of Sydney, Westmead, New South Wales, Australia. · Pubmed 25628259
2014
  • Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 24946815
  • Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 24528820
Probable:    University of Sydney      
2019
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Pubmed 30392112
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 30178142
2018
  • Chris O'Brien Lifehouse, Medical Oncology Department, Camperdown, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Wyong Public Hospital, Gastroenterology Department, NSW, Australia. · Pubmed 29370723
2017
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Centenary Institute, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Nepean Hospital, Sydney, New South Wales, Australia. · Kossard Dermatopathologists, Sydney, New South Wales, Australia. · Pathology North - Hunter, Newcastle, New South Wales, Australia. · John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia. · University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 28480561
2016
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • aDoherty Institute for Infection and Immunity, University of Melbourne bDepartment of Infectious Diseases, Alfred Hospital and Monash University cCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria dDepartment of Medical Oncology eDepartment of Clinical Immunology, Royal Prince Alfred Hospital, Sydney fWestmead Millenium Institute, University of Sydney, Westmead, New South Wales, Australia. · Pubmed 25628259
Probable:    Miscellaneous institutions in Sydney      
2019
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Pubmed 30392112
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 30178142
2018
  • Chris O'Brien Lifehouse, Medical Oncology Department, Camperdown, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Wyong Public Hospital, Gastroenterology Department, NSW, Australia. · Pubmed 29370723
  • a Chris O'Brien Lifehouse , Sydney , Australia. · b Royal Prince Alfred Hospital , Sydney , Australia. · Pubmed 27892777
2017
  • Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Centenary Institute, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Nepean Hospital, Sydney, New South Wales, Australia. · Kossard Dermatopathologists, Sydney, New South Wales, Australia. · Pathology North - Hunter, Newcastle, New South Wales, Australia. · John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia. · University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 28480561
2016
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
2015
  • a Department of Medical Oncology, Chris O'Brien Lifehouse, 119-143 Missenden Road, Camperdown NSW 2050, PO BOX M33 Missenden Road NSW 2050, Australia. · Pubmed 26146011
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 22 total) written by Catriona Mairi McNeil about Melanoma:

  • Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial. 2019
  • Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma. 2019
  • A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability. 2019
  • Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy. 2019
  • Isolated immune-related pancreatic exocrine insufficiency associated with pembrolizumab therapy. 2018
  • Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report. 2018
  • Clinical Nurse Consultant Support: Management of Patients With Melanoma Receiving Immunotherapy 
and Targeted Therapy
. 2017
  • Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). 2017
  • Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial. 2017
  • Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial. 2017
Show List of Full Article Records
Google Searches

Learn more about Catriona Mairi McNeil using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Royal Prince Alfred Hospital
University of Sydney
Miscellaneous institutions in Sydney
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Royal Prince Alfred Hospital
2019
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia. · Department of Medicine, Institute Gustave Roussy, Villejuif, France. · Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia. · Dermatology Service, University Hospital of Bordeaux, Bordeaux, France. · UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France. · Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. · Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Assistance Publique-Hôpitaux de Paris Dermatology and Centre d'Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France. · Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France. · Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Department of Dermatology, University Hospital Cologne, Cologne, Germany. · Division of Oncology, Regina Elena Institute, Rome, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark. · Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey. · Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia. · Pubmed 30422243
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, The University of Melbourne, 305 Grattan Street, Melbourne, VIC, 3000, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, CA, USA. · Genentech, Inc., South San Francisco, CA, USA. · Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia. · The Angeles Clinic and Research Institute, California, Los Angeles, USA. · Sarah Cannon Research Institute/Tennessee Oncology, PPLC, Nashville, TN, USA. · Pubmed 31385109
2018
  • Chris O'Brien Lifehouse, Medical Oncology Department, Camperdown, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Wyong Public Hospital, Gastroenterology Department, NSW, Australia. · Pubmed 29370723
  • a Chris O'Brien Lifehouse , Sydney , Australia. · b Royal Prince Alfred Hospital , Sydney , Australia. · Pubmed 27892777
2017
  • Division of Oncology, Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. Electronic address: · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney, Mater Hospital and Royal North Shore Hospital, Sydney, Australia. · Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital de la Timone, Marseille, France. · Department of Dermatology, Université Lille, INSERM U1189, CHU Lille, F-59000, France. · Department of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, USA. · Department of Medical Oncology, Westmead and Blacktown Hospitals, Melanoma Institute Australia, and The University of Sydney, Sydney, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, and Melanoma Institute Australia, Camperdown, Australia. · Department of Melanoma and Cancer Immunotherapy, Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Department of Medical Oncology University of Manchester and the Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medicine, Division of Medical Oncology/Hematology, Sunnybrook Health Sciences Center, Toronto, ON, Canada. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Department of BARDS, Merck & Co, Kenilworth, NJ, USA. · Department of Clinical Oncology, Merck & Co, Kenilworth, NJ, USA. · Department of Oncology, Gustave Roussy and Paris-Sud University, Villejuif, France. · Pubmed 28822576
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Mater Hospital, North Sydney, New South Wales, Australia. · Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · now with Department of Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York. · Department of Oncology, Royal Marsden Hospital, London, United Kingdom. · Gallipoli Medical Research Foundation and Princess Alexandra Hospital, and University of Queensland, Queensland, Australia. · Department of Dermatology and Skin Cancer, Hospital Timone APHM, Aix-Marseille University, Marseille, France. · Department of Skin, University Hospital Essen, Essen, Germany. · Department of Urology, University Hospital Essen, Essen, Germany. · Department of Dermatology, UniversitaetsSpital, Zurich, Switzerland. · Department of Medicine Institute Gustave Roussy, Gustave Roussy and Paris-Sud University, Villejuif Paris-Sud, France. · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales, Australia. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Oncology, Coffs Harbour Health Campus, New South Wales, Australia. · Melanoma Clinic at King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium. · Melanoma Center and Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28662232
  • Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Centenary Institute, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Nepean Hospital, Sydney, New South Wales, Australia. · Kossard Dermatopathologists, Sydney, New South Wales, Australia. · Pathology North - Hunter, Newcastle, New South Wales, Australia. · John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia. · University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 28480561
2016
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • A.W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 25641691
  • aDoherty Institute for Infection and Immunity, University of Melbourne bDepartment of Infectious Diseases, Alfred Hospital and Monash University cCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria dDepartment of Medical Oncology eDepartment of Clinical Immunology, Royal Prince Alfred Hospital, Sydney fWestmead Millenium Institute, University of Sydney, Westmead, New South Wales, Australia. · Pubmed 25628259
2014
  • Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 24946815
  • Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 24528820
University of Sydney
2019
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Pubmed 30392112
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 30178142
2018
  • Chris O'Brien Lifehouse, Medical Oncology Department, Camperdown, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Wyong Public Hospital, Gastroenterology Department, NSW, Australia. · Pubmed 29370723
2017
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Centenary Institute, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Nepean Hospital, Sydney, New South Wales, Australia. · Kossard Dermatopathologists, Sydney, New South Wales, Australia. · Pathology North - Hunter, Newcastle, New South Wales, Australia. · John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia. · University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 28480561
2016
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • aDoherty Institute for Infection and Immunity, University of Melbourne bDepartment of Infectious Diseases, Alfred Hospital and Monash University cCentre for Biomedical Research, Burnet Institute, Melbourne, Victoria dDepartment of Medical Oncology eDepartment of Clinical Immunology, Royal Prince Alfred Hospital, Sydney fWestmead Millenium Institute, University of Sydney, Westmead, New South Wales, Australia. · Pubmed 25628259
Miscellaneous institutions in Sydney
2019
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Pubmed 30392112
  • Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Centre for Medical Psychology and Evidence-Based Decision-Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Chris O'Brien Lifehouse Comprehensive Cancer Centre, Missenden Rd, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Pubmed 30178142
2018
  • Chris O'Brien Lifehouse, Medical Oncology Department, Camperdown, NSW, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, NSW, Australia. · Wyong Public Hospital, Gastroenterology Department, NSW, Australia. · Pubmed 29370723
  • a Chris O'Brien Lifehouse , Sydney , Australia. · b Royal Prince Alfred Hospital , Sydney , Australia. · Pubmed 27892777
2017
  • Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Centenary Institute, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Nepean Hospital, Sydney, New South Wales, Australia. · Kossard Dermatopathologists, Sydney, New South Wales, Australia. · Pathology North - Hunter, Newcastle, New South Wales, Australia. · John Hunter and Calvary Mater Hospitals, Newcastle, New South Wales, Australia. · University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 28480561
2016
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · The Strathfield Breast Centre, Strathfield, NSW, Australia. · Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia. · Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia. · Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. · Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia. · Pubmed 26588661
2015
  • a Department of Medical Oncology, Chris O'Brien Lifehouse, 119-143 Missenden Road, Camperdown NSW 2050, PO BOX M33 Missenden Road NSW 2050, Australia. · Pubmed 26146011
Mater Hospital
2019
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia. · Department of Medicine, Institute Gustave Roussy, Villejuif, France. · Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia. · Dermatology Service, University Hospital of Bordeaux, Bordeaux, France. · UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France. · Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. · Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Assistance Publique-Hôpitaux de Paris Dermatology and Centre d'Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France. · Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France. · Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Department of Dermatology, University Hospital Cologne, Cologne, Germany. · Division of Oncology, Regina Elena Institute, Rome, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark. · Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey. · Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia. · Pubmed 30422243
2017
  • Division of Oncology, Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. Electronic address: · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney, Mater Hospital and Royal North Shore Hospital, Sydney, Australia. · Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital de la Timone, Marseille, France. · Department of Dermatology, Université Lille, INSERM U1189, CHU Lille, F-59000, France. · Department of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, USA. · Department of Medical Oncology, Westmead and Blacktown Hospitals, Melanoma Institute Australia, and The University of Sydney, Sydney, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, and Melanoma Institute Australia, Camperdown, Australia. · Department of Melanoma and Cancer Immunotherapy, Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Department of Medical Oncology University of Manchester and the Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medicine, Division of Medical Oncology/Hematology, Sunnybrook Health Sciences Center, Toronto, ON, Canada. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Department of BARDS, Merck & Co, Kenilworth, NJ, USA. · Department of Clinical Oncology, Merck & Co, Kenilworth, NJ, USA. · Department of Oncology, Gustave Roussy and Paris-Sud University, Villejuif, France. · Pubmed 28822576
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Mater Hospital, North Sydney, New South Wales, Australia. · Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · now with Department of Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York. · Department of Oncology, Royal Marsden Hospital, London, United Kingdom. · Gallipoli Medical Research Foundation and Princess Alexandra Hospital, and University of Queensland, Queensland, Australia. · Department of Dermatology and Skin Cancer, Hospital Timone APHM, Aix-Marseille University, Marseille, France. · Department of Skin, University Hospital Essen, Essen, Germany. · Department of Urology, University Hospital Essen, Essen, Germany. · Department of Dermatology, UniversitaetsSpital, Zurich, Switzerland. · Department of Medicine Institute Gustave Roussy, Gustave Roussy and Paris-Sud University, Villejuif Paris-Sud, France. · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales, Australia. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Department of Medical Oncology, Coffs Harbour Health Campus, New South Wales, Australia. · Melanoma Clinic at King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium. · Melanoma Center and Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28662232
2016
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
Unspecified
2017
  • Chris O'Brien Lifehouse. · Royal Prince Alfred Hospital. · Dubbo Base Hospital. · University of Sydney. · Pubmed 28738040
2015
5 Other Locations Show
Yearly article counts 04262620000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.